The group's third-quarter sales were down 8.2%, mainly in France where sales dropped 13.9%. The situation in Europe shows sharp contrasts, with sales increasing in Italy and decreasing in Spain. In North America, the United States posted a significant increase in sales.
At the end September, group sales were down 8.4%, hard hit by the 11.7% drop in sales of Non-proprietary Homeopathic medicines and Specialties in France, where homeopathy is under attack.
In Europe, the decrease in sales in Spain, Belgium, and Poland was partially offset by increased sales in Italy and Bulgaria.
In North America, sales were up in the second and third quarters but cumulative turnover is still down due to the drop in first quarter sales.
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer